Lyra Therapeutics Announces Completion of Enrollment in the
-- Topline Results Expected in Q4 2023 -- -- LYR-220 is Lyra’s Second Product Candidate, Following LYR-210 in Surgically-Naïve CRS patients -- WATERTOWN,...
Source: globenewswire.com
Second Product Candidate News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Second Product Candidate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.